Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery

Adroit BioMed launches Fortisil range of skincare products

Biological E. reduces Corbevax price to Rs.250 a dose

The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12

Erectile dysfunction drugs help prevent death and complications due to heart disease

Huntington Medical Research Institutes present first-of-its-kind study examining impact of erectile dysfunction drugs on major adverse cardiovascular events and mortality

CCMB develops India’s first mRNA vaccine technology

The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose

CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine

CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium

Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery

Aims to increase compliance and improve outcomes for People with Diabetes (PwD)

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses

Thieme EIDO Healthcare launches digital consent platform with Indian Medical Association

The aim is to bring patient consent tools in a digital format in addition to a paper format which is not just a need of the current times but also a way forward